Last updated: 27 November 2023 at 4:50pm EST

Steven Pacelli Net Worth

The estimated Net Worth of Steven Robert Pacelli is at least 58.8 百万$ dollars as of 24 November 2023. Mr. Pacelli owns over 411 units of Dexcom Inc stock worth over 8,543,344$ and over the last 19 years he sold DXCM stock worth over 47,199,925$. In addition, he makes 3,020,340$ as Executive Vice President - Strategy and Corporate Development at Dexcom Inc.

Mr. Pacelli DXCM stock SEC Form 4 insiders trading

Steven has made over 128 trades of the Dexcom Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 411 units of DXCM stock worth 45,539$ on 24 November 2023.

The largest trade he's ever made was exercising 75,000 units of Dexcom Inc stock on 26 February 2013 worth over 239,250$. On average, Steven trades about 5,699 units every 24 days since 2006. As of 24 November 2023 he still owns at least 124,775 units of Dexcom Inc stock.

You can see the complete history of Mr. Pacelli stock trades at the bottom of the page.

Steven Pacelli biography

Steven R. Pacelli serves as Executive Vice President - Strategy and Corporate Development of the Company. Mr. Pacelli has served as our Executive Vice President of Strategy and Corporate Development since August 2012. Mr. Pacelli has served in roles of increasing responsibility with DexCom since April 2006, including as its Chief Operating Officer from June 2010 to August 2012, Chief Administrative Officer from December 2008 to June 2010, Senior Vice President of Corporate Affairs from June 2007 to December 2008, and Vice President of Legal Affairs from April 2006 to June 2007. Prior to joining DexCom, Mr. Pacelli served as a corporate attorney specializing in finance, mergers and acquisitions, and general corporate matters, and also in an executive role as general counsel of several privately held companies. Mr. Pacelli received a BA from the University of California, Los Angeles, and a J.D. from the University of Virginia. Mr. Pacelli is a member of the State Bar of California.

What is the salary of Steven Pacelli?

As the Executive Vice President - Strategy and Corporate Development of Dexcom Inc, the total compensation of Steven Pacelli at Dexcom Inc is 3,020,340$. There are 4 executives at Dexcom Inc getting paid more, with Kevin Sayer having the highest compensation of 10,279,400$.

How old is Steven Pacelli?

Steven Pacelli is 48, he's been the Executive Vice President - Strategy and Corporate Development of Dexcom Inc since 2012. There are 21 older and 8 younger executives at Dexcom Inc. The oldest executive at Dexcom Inc is Andrew K. Balo, 73, who is the Exec. VP of Regulatory Strategy, Clinical Affairs & Strategic Partnership Devel..

What's Steven Pacelli's mailing address?

Steven's mailing address filed with the SEC is 6340, Sequence Drive, Sorrento Valley, San Diego, San Diego County, California, 92121, United States.

Insiders trading at Dexcom Inc

Over the last 20 years, insiders at Dexcom Inc have traded over 724,717,982$ worth of Dexcom Inc stock and bought 165,450 units worth 3,489,100$ . The most active insiders traders include Sean Carney、Kim D Blickenstaff、Steven R Altman. On average, Dexcom Inc executives and independent directors trade stock every 7 days with the average trade being worth of 892,438$. The most recent stock trade was executed by Sadie Stern on 9 September 2024, trading 426 units of DXCM stock currently worth 29,458$.

What does Dexcom Inc do?

founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.

Complete history of Mr. Pacelli stock trades at Dexcom Inc

インサイダー	取引取引	合計金額
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	45,539$ 24 Nov 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	35,243$ 23 Oct 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	36,332$ 22 Sep 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	43,989$ 23 Aug 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	53,799$ 24 Jul 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	684,216$ 14 Jul 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	51,879$ 23 Jun 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	48,884$ 23 May 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	633,906$ 27 Apr 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	51,368$ 24 Apr 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	633,449$ 23 Mar 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	45,996$ 23 Feb 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	44,438$ 23 Jan 2023
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	46,379$ 23 Dec 2022
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	84,210$ 23 Aug 2022
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	83,070$ 25 Jul 2022
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	72,550$ 23 Jun 2022
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	74,083$ 24 May 2022
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	109,985$ 25 Apr 2022
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	114,995$ 23 Mar 2022
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	98,583$ 23 Feb 2022
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	104,193$ 24 Jan 2022
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	143,478$ 23 Dec 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	153,065$ 23 Nov 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	142,500$ 22 Oct 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	3,866,032$ 23 Sep 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	683,750$ 9 Sep 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	556,679$ 23 Aug 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	487,902$ 23 Jul 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	460,647$ 23 Jun 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	376,258$ 24 May 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	442,724$ 23 Apr 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	388,969$ 23 Mar 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	2,020,013$ 10 Mar 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	439,131$ 23 Feb 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	756,018$ 19 Feb 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	397,957$ 22 Jan 2021
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	388,278$ 23 Dec 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	344,190$ 23 Nov 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	435,031$ 23 Oct 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	904,640$ 30 Sep 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	800,140$ 25 Sep 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	426,324$ 23 Sep 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	1,824,214$ 9 Sep 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	654,104$ 24 Aug 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	654,212$ 23 Jul 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	626,745$ 23 Jun 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	607,409$ 22 May 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	487,731$ 23 Apr 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	320,331$ 13 Mar 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	2,131,536$ 11 Mar 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	87,485$ 5 Mar 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	425,327$ 24 Feb 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	358,978$ 23 Jan 2020
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	326,576$ 23 Dec 2019
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	333,302$ 22 Nov 2019
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	233,431$ 23 Oct 2019
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	238,180$ 23 Sep 2019
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	875,632$ 9 Sep 2019
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	466,309$ 24 Jun 2019
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	419,806$ 23 May 2019
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	419,330$ 23 Apr 2019
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	503,584$ 22 Mar 2019
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	1,543,703$ 12 Mar 2019
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	241,165$ 22 Feb 2019
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	466,290$ 23 Jan 2019
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	340,703$ 21 Dec 2018
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	378,102$ 23 Nov 2018
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	401,239$ 23 Oct 2018
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	439,853$ 24 Sep 2018
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	788,236$ 10 Sep 2018
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	435,835$ 23 Aug 2018
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	317,348$ 25 Jul 2018
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	21,784$ 10 May 2018
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	174,348$ 29 Nov 2017
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	101,225$ 25 Sep 2017
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	300,062$ 23 Aug 2017
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	100,732$ 24 Jul 2017
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	113,376$ 23 Jun 2017
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	98,948$ 23 May 2017
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	110,041$ 24 Apr 2017
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	304,009$ 23 Mar 2017
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	75,072$ 23 Jan 2017
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	75,072$ 23 Jan 2017
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	724,296$ 23 Nov 2016
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	844,085$ 24 Oct 2016
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	968,200$ 23 Sep 2016
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	934,622$ 23 Aug 2016
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	45$ 8 Aug 2016
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	899,499$ 25 Jul 2016
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	797,220$ 23 Jun 2016
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	1,292,780$ 8 Jun 2016
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	166,191$ 27 Apr 2016
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	1,454,772$ 4 Apr 2016
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	754,372$ 25 Jan 2016
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	147,000$ 23 Dec 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	137,200$ 23 Nov 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	371,750$ 10 Nov 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	137,200$ 23 Oct 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	137,200$ 23 Sep 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	1,879,578$ 28 Aug 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	137,200$ 24 Aug 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	128,100$ 23 Jul 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	109,060$ 23 Jun 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	109,060$ 26 May 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	640,109$ 21 Apr 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	379,600$ 9 Apr 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	109,060$ 23 Mar 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	109,060$ 23 Feb 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	228,393$ 23 Jan 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	333,872$ 12 Jan 2015
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	107,100$ 23 Dec 2014
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	282,375$ 24 Nov 2014
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	106,820$ 23 Oct 2014
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	106,820$ 23 Sep 2014
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	437,100$ 25 Aug 2014
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	106,820$ 23 Jul 2014
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	104,300$ 23 Jun 2014
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	101,500$ 23 May 2014
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	101,500$ 23 Apr 2014
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	101,500$ 24 Mar 2014
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	456,808$ 24 Feb 2014
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	44,660$ 23 Jan 2014
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	73,370$ 19 Nov 2013
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	38,280$ 14 Nov 2013
Steven Robert Pacelli EVP Managing Director Dexcom V	販売	111,550$ 10 Jun 2013
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	239,250$ 26 Feb 2013
Steven Robert Pacelli EVP Managing Director Dexcom V	オプション行使	31,900$ 11 Dec 2012

Dexcom Inc executives and stock owners

Dexcom Inc executives and other stock owners filed with the SEC include:

Kevin Sayer,
Chairman of the Board, President, Chief Executive Officer
Quentin Blackford,
Chief Financial Officer, Chief Operating Officer
Richard Doubleday,
Executive Vice President, Chief Commercial Officer
Andrew Balo,
Executive Vice President - Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development
Steven Pacelli,
Executive Vice President - Strategy and Corporate Development
Donald Abbey,
Executive Vice President - Quality and Regulatory Affairs
Kevin Ronald Sayer,
Exec. Chairman, CEO & Pres
Jacob Steven Leach,
Exec. VP & CTO
Bridgette Heller,
Independent Director
Mark Foletta,
Lead Independent Director
Eric Topol,
Independent Director
Jay Skyler,
Independent Director
Nicholas Augustinos,
Independent Director
Steven Altman,
Independent Director
Barbara Kahn,
Independent Director
Richard Collins,
Independent Director
Kyle Malady,
Independent Director
Karen Dahut,
Independent Director
Shelly Selvaraj,
Senior Vice President - Information Technology
Jeffrey Moy,
Senior Vice President - Operations
Jereme Sylvain,
Senior Vice President - Finance, Chief Accounting Officer
Patrick Murphy,
Executive Vice President, Chief Legal Officer
Jake Leach,
Executive Vice President, Chief Technology Officer
Shelly Ramasamy Selvaraj,
Sr. VP of Information Technology
Donald M. Abbey,
Exec. VP of Global Bus. Services, IT, Quality & Regulatory Affairs
Steven R. Pacelli,
Exec. VP & MD of Dexcom Ventures
Andrew K. Balo,
Exec. VP of Regulatory Strategy, Clinical Affairs & Strategic Partnership Devel.
Sadie M. Stern,
Exec. VP & Chief HR Officer
Chad M. Patterson,
Exec. VP of Global Marketing
Sean Christensen,
Director of Corp. Affairs & Head of Investor Relations
Jereme M. Sylvain,
Exec. VP, CFO & Chief Accounting Officer
John Lister,
VP, Legal Affairs
Terrance H Gregg,
Director
Jess Roper,
VP, CFO
Jorge A Valdes,
Vice President of Engineering
Girish Naganathan,
EVP Chief Technology Officer
Heather S Ace,
SVP Human Resources
Kevin M Sun,
VP, Corp Controller & Treasury
Jonathan T Md Lord,
Director
Glen D Nelson,
Director
Peter Gerhardsson,
VP, Int'l Business Development
David Carner,
VP, Quality Assurance
Laura Johnson,
V.P., Intellectual Property
Martin Doordan,
Director
Sean Carney,
Director
John Riolo,
VP of Quality Assurance
Claudia Graham,
VP, Marketing
Donald A Lucas,
Director
Donald L Lucas,
Director
Mark Brister,
VP, Advanced Development Teams
Richard Yang,
V.P., Strategic Affairs
James H Brauker,
VP, Research & Development
Rodney L Kellogg,
Vice President of Sales
Andrew P Rasdal,
President and CEO
Steven J Kemper,
Chief Financial Officer
Kim D Blickenstaff,
Director
Tae Andrews,
Vice President of Marketing
Paul Travelers Companies In...,
Pincus Private Equity Viii ...,
Brenton Karl Ahrens,
Director
Nancy Sfog City Management ...,
Equity Partners Ii Llccanaa...,
Paul Travelers Companies In...,
Eric A Charmers Landing Llc...,
Scott Lwindamere Llcwindame...,
Equity Partners Ii Llc Waub...,
Teri L Lawver,
EVP Chief Commercial Officer
Paul R Flynn,
EVP Global Revenue
Matthew Vincent Dolan,
EVP Strategy and Corporate Dev
Sumi Shrishrimal,
SVP Chief Risk Officer
Chad Patterson,
EVP Global Marketing
Barry J. Regan,
EVP Operations
Jacob Steven Leach,
EVP, Chief Operating Officer
Rimma Driscoll,
Director
Michael Jon Brown,
EVP, Chief Legal Officer
Sadie Stern,
EVP, Chief HR Officer